ELDRED KARY purchased 1.1% of their position (700.00 shares) of GALECTIN THERAPEUTICS INC on the open market
Open‑market purchase worth $2.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/23/2025ACC: 0001133416-25-000074
+700.00
Net shares
Net buyer
$2.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
700.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+700.00
Price / share
$3.73
Trade value
$2.61K
% of position
1.1%
12/23/2025
64.68K→65.38K
Total
Net shares
+700.00
Net value
$2.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2025 | P · Purchase | +700.00 | $3.73 | $2.61K | 1.1% | 64.68K | 65.38K |
| Total | +700.00 | $2.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.42K
Common Stock
IndirectShares owned2K
Total
4.42K indirect4.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.42K | Indirect |
| Common Stock | 2K | Indirect |
| Total | 4.42K | 4.42K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported